Trial Profile
Phase I trial of RG7116 in patients with solid tumours
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2012
Price :
$35
*
At a glance
- Drugs Lumretuzumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 27 Apr 2012 New trial record